Emulate Energy and Smartcar Partner to Drive EV Utilization as Distributed Energy Resources
14.11.2024 08:00:00 CET | Business Wire | Press Release
Emulate Energy, distributed energy resource management system (DERMS) software, today announced a partnership with Smartcar, the leading API platform for mobility businesses. By seamlessly integrating EVs into its platform, Emulate offers energy providers a comprehensive solution to simplify onboarding and management of different consumer distributed energy resources (DERs).
This partnership enables energy providers using Emulate to use EV charging flexibility effectively as a way to balance the grid, reduce peak demand, and improve overall grid reliability.
Enabling reliable EV integration for energy providers
By expanding its EV support to a wider range of models, Emulate is enabling energy providers to harness the power of EVs as a valuable energy resource. Smartcar helps Emulate automate EV data retrieval to optimize charging schedules based on different pricing factors. Consumers can set their preferred charging preferences using the software and have peace of mind knowing Emulate will handle the rest.
Reliable EV integrations are crucial for enabling this convenience and giving consumers a single platform to enroll and manage different devices.
“Emulate aspires to connect to and control every energy device possible. While controls and market participation are our bread-and-butter, for EVs specifically, Smartcar makes it super easy to connect to vehicles regardless of manufacturer and model,” says Blake Davis, Senior Director of US Operations at Emulate.
A strategic partnership for scalability
Emulate’s decision to partner with Smartcar was driven by the need for a reliable and scalable solution that they could implement quickly without straining engineering resources. Smartcar ensures accurate and timely action, like retrieving an EV’s state of charge and automatically starting and stopping charging sessions. Smartcar is compatible with over 35 EV brands and seamlessly integrates into Emulate’s out-of-the-box vehicle onboarding solution.
Beyond endpoints, Smartcar’s developer tools and webhooks make it easy for Emulate’s engineering team to receive data at a regular cadence while reducing server loads, reducing latency, and ensuring the timeliness and accuracy of charging data.
A shared vision for the future of distributed energy
“Emulate’s commitment to energy flexibility and reliability aligns perfectly with Smartcar’s mission. By simplifying EV integrations and enabling proactive load control, we’re excited to help Emulate empower drivers to reduce their energy costs, support grid stability, and contribute to a more sustainable future,” says Sahas Katta, CEO and Co-founder at Smartcar.
This partnership will help address the challenges associated with EV enrollment and retention in demand response programs. Emulate and Smartcar aim to increase EV participation and drive long-term adoption by simplifying EV onboarding processes, improving feature reliability, and providing a user-friendly experience for all consumers.
About Emulate
Emulate Energy is a rapidly growing software company from Sweden, the forefront of the energy transition. Founded in 2020 based on research conducted at MIT, the company aims to expedite the global shift to sustainable power. Emulate’s cutting-edge software optimizes the energy consumption of common devices—air conditioners, heat pumps, and EV chargers— to save consumers money while enhancing utility profits by aggregating these devices into “virtual batteries” that can be dispatched or traded on electricity markets. Tailored for utilities by utilities, our solutions have impacted thousands of customers across Europe and the US, contributing to a greener, more robust energy future.
About Smartcar
Smartcar, the leading API platform for connected vehicles, empowers businesses to develop mobility solutions that put drivers in control of their vehicle data. Founded in 2015, Smartcar provides developer tools to help companies integrate with cars using a unified API, manage API connections, and implement consent management. Smartcar unlocks the freedom of movement for everyone by removing barriers to mobility app development and helping vehicle owners choose how they want to use their car data — whether that’s on solutions for energy management, vehicle repairs, EV charging, rideshare, auto insurance, and more. Smartcar has raised $36M to date and is backed by Andreessen Horowitz (a16z), New Enterprise Associates (NEA), and Energize Capital.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241113990311/en/
Contacts
Winona Rajamohan
Smartcar
winona@smartcar.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 20263.10.2026 16:50:00 CEST | Press Release
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1b C-800-01 trial. The study evaluated botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), Agenus’ anti-PD-1 antibody. The results, including three-year survival and outcomes by sensitivity to platinum-based chemotherapy and by prior treatment, were presented at the 2026 International Gynecologic Cancer Society (IGCS) Annual Global Meeting in Montréal, Canada. Among patients evaluable for efficacy, three-year overall survival was 48% (n=35), unchanged from the two-year estimate, suggesting durable clinical benefit in this population. Responses and long-term survival were observed in both platinum-sensitive and platinum-resistant or refractory disease. At the last follow-up, 25% of patients who received at least one dose of treatment (11 of 44) were alive
emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer2.10.2026 17:12:00 CEST | Press Release
emnify, a global leader in IoT connectivity, today announced the appointments of Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer, effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001902751/en/ emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer The appointments follow the recent naming of Kenneth De Spiegeleire as Chief Executive Officer and Frank Stoecker as Executive Chairman of the Board. Together, these leadership changes strengthen emnify financial, operational, and commercial capabilities as the company enters its next phase of international growth. “We have proven momentum. Our ambition is to now turn it into global category leadership,” said Kenneth De Spiegeleire, CEO of emnify. “That requires sharper focus, disciplined execution, and the right capabilities in the right seats. Sacha brings financial lead
Tacton Appoints Former IFS Executive Merlin Knott as Chief Commercial Officer to Accelerate Global Growth and Scale Beyond CPQ2.10.2026 15:00:00 CEST | Press Release
Tacton, a global leader in Configure, Price, Quote (CPQ) software and configuration solutions for manufacturers of complex products, today announced the appointment of Merlin Knott as Chief Commercial Officer (CCO). In this role, Knott will lead Tacton’s global commercial organization, including marketing, sales, and pre-sales, aligning the teams responsible for bringing Tacton’s solutions to market, and driving value to its customers and partners globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261002794882/en/ Merlin Knott, Chief Commercial Officer, Tacton Knott joins Tacton with decades of experience building and scaling commercial organizations across the enterprise software industry. Most recently, he held senior leadership roles at IFS, the world’s leading provider of Industrial AI software, where he led global partner and channel operations before becoming President of the company’s Enterprise Service Manageme
EDW Presents 2026 Data Quality Award to Repeat Winner Domivest2.10.2026 15:00:00 CEST | Press Release
European DataWarehouse (EDW) presented its fifth annual Data Quality Award at the 2026 TSI Congress in Berlin. This year, EDW's Best Data Quality – Deal of the Year (2026) award was presented to Domivest B.V. for its transaction Domi 2023-1 B.V., recognising the firm's outstanding commitment to accurate, complete, and consistent reporting. The award is based on EDW's proprietary data quality scoring methodology, which evaluates transactions against thousands of validation rules and checks. Data quality excellence is not a one-off achievement. The fact that the same issuers continue to rank among the top performers year after year demonstrates that superior data quality is the result of sustained commitment, robust processes, and ongoing investment. "Receiving the Data Quality Award for a second time means a great deal to us. Transparent, accurate loan-level data is key to investor trust in our transactions, and we are grateful to European DataWarehouse for recognising the work our trea
ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases2.10.2026 14:00:00 CEST | Press Release
ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the publication of results from its Phase 2b SUPER (Stand Up to Pertussis) clinical trial in The Lancet Infectious Diseases. This randomized, double blind, placebo- and active-comparator-controlled trial demonstrated that BPZE1, a live attenuated intranasal pertussis vaccine, induced robust nasal mucosal immune responses in healthy children aged 6 through 17 years (LINK). The study demonstrated that a single intranasal dose of BPZE1 induced nasal mucosal immune responses against all Bordetella pertussis antigens tested and was well tolerated, both when administered alone and when co-administered with a tetanus-diphtheria-acellular pertussis (Tdap) booster vaccine. The multi-center Phase 2b trial enrolled 366 participants across 16 sites in the United Kingdom, Australia, and Costa Rica and included participants
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom